Ambit Biosciences Corp. (AMBI) was a big mover last session, as its shares rose over 7% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down over 31% in the past one-month time frame.
In the last 60 days, the company witnessed two negative estimate revisions and its Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
Ambit Biosciences currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked medical stocks include Lannett Company, Inc. (LCI), Jazz Pharmaceuticals plc (JAZZ) and Questcor Pharmaceuticals, Inc. (QCOR). All three companies carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
AMBIT BIOSCIENCES CORP (AMBI): Free Stock Analysis Report
JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report
LANNETT COMP (LCI): Free Stock Analysis Report
QUESTCOR PHARMACEUTICALS INC (QCOR): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Health Care Industry